Radionuclide Therapy:Astatin・Others 2

[M2B6C3] Manufacture and quality evaluation using synthesizer of [211At]MABG

Miho Aoki¹, Katsuyuki Minegishi², Hisashi Suzuki², Takashi Oda³, Shigenori Sasaki⁴, Koshin Washiyama¹, Kenichi Nishijima¹, Songji Zhao¹, kotaro Nagatsu², Ming-Rong Zhang², Kazuhiro Takahashi¹ (1.Advanced Clinical Research Center, Fukushima Medical University, Fukushima, Japan, 2.National Institutes for Quantum and Radiological Science and Technology, National Institute of Radiological Sciences, 3.Sumitomo Heavy Industries, Ltd., 4.SHI Accelerator Service Ltd.)